New drug trial aims to protect kidneys in diabetic patients
NCT ID NCT07496177
Summary
This study is testing whether an investigational drug called HTD1801 can slow the worsening of kidney disease in adults who have both Type 2 Diabetes and Chronic Kidney Disease. About 75 participants will be randomly assigned to take either HTD1801 or a placebo (inactive pill) twice daily for 12 weeks. Researchers will measure changes in key kidney health markers to see if the drug is effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CKD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Weifang People's Hospital
Weifang, Shandong, 261000, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.